High Incidence of Curable Sexually Transmitted Infections Among Persons Accessing Oral Preexposure Prophylaxis at an Integrated Sexually Transmitted Infection/Preexposure Prophylaxis Clinic in Lilongwe, Malawi

Incident, asymptomatic STIs in the 6 months after PrEP initiation were common. Testing of STI contextualizes perceived HIV risk and may encourage PrEP persistence. Integrating bacterial STI testing within PrEP care may reduce transmission via expedient treatment and should be considered alongside PrEP program expansion.Clinical Trial Number: NCT05307991 ( https://clinicaltrials.gov/ct2/show/NCT05307991 ).

Authors

Institutions

Publication Details

Journal
Sexually Transmitted Diseases
Published
2025-04-22
DOI
https://doi.org/10.1097/olq.0000000000002170
Primary Topic
HIV/AIDS Research and Interventions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

High Incidence of Curable Sexually Transmitted Infections Among Persons Accessing Oral Preexposure Prophylaxis at an Integrated Sexually Transmitted Infection/Preexposure Prophylaxis Clinic in Lilongwe, Malawi

Mina C. Hosseinipour, Grace E. Mulholland, Gabriel Banda, Sarah E. Rutstein et al.
1 links
Sexually Transmitted Diseases
HIV/AIDS Research and Interventions
article

High Incidence of Curable Sexually Transmitted Infections Among Persons Accessing Oral Preexposure Prophylaxis at an Integrated Sexually Transmitted Infection/Preexposure Prophylaxis Clinic in Lilongwe, Malawi

Mina C. Hosseinipour, Grace E. Mulholland, Gabriel Banda, Sarah E. Rutstein, Naomi Nyirenda, Jane S. Chen, Mitch Matoga, Edward Jere, Esther Mathiya, Irving Hoffman, Laura Limarzi-Klyn, Zakaliah Mphande
article en

Abstract

Incident, asymptomatic STIs in the 6 months after PrEP initiation were common. Testing of STI contextualizes perceived HIV risk and may encourage PrEP persistence. Integrating bacterial STI testing within PrEP care may reduce transmission via expedient treatment and should be considered alongside PrEP program expansion.Clinical Trial Number: NCT05307991 ( https://clinicaltrials.gov/ct2/show/NCT05307991 ).

Sexually Transmitted DiseasesVol. 52(9)
University of North Carolina at Chapel Hill (US), Lighthouse Trust (MW)
Good health and well-being
Openalex Percentile: Top 89%
HIV/AIDS Research and Interventions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.